Pfizer Inc. (PFE) Q2 2024 Earnings Call Transcript

SA Transcripts
153.96K Followers

Q2: 2024-07-30 Earnings Summary

EPS of $0.60 beats by $0.14
 | Revenue of $13.28B (4.31% Y/Y) beats by $263.90M

Pfizer Inc. (NYSE:PFE) Q2 2024 Earnings Conference Call July 30, 2024 10:30 AM ET

Company Participants

Francesca DeMartino – Chief Investor Relations Officer and Senior Vice President
Albert Bourla – Chairman and Chief Executive Officer
Dave Denton – Chief Financial Officer
Chris Boshoff – Executive Vice President and Chief Oncology Officer
Alexandre de Germay – Executive Vice President and Chief International Commercial Officer
Mikael Dolsten – Chief Scientific Officer and President of Research & Development
Aamir Malik – Executive Vice President and Chief U.S. Commercial Officer

Conference Call Participants

Louise Chen – Cantor
Mohit Bansal – Wells Fargo
Terence Flynn – Morgan Stanley
Alex Hammond – Bank of America
Akash Tewari – Jefferies
Chris Shibutani – Goldman Sachs
Dave Risinger – Leerink Partners
Kripa Devarakonda – Truist Securities
Trung Huynh – UBS
Carter Gould – Barclays
Chris Schott – JPMorgan
Tim Anderson – Wolfe Research
Steve Scala – TD Cowen
Vamil Divan – Guggenheim Securities
Evan Seigerman – BMO Capital Markets

Operator

Good day, everyone, and welcome to Pfizer's Second Quarter 2024 Earnings Conference Call. Today's call is being recorded.

At this time, I would like to turn the call over to Francesca DeMartino, Chief Investor Relations Officer and Senior Vice President. Please go ahead, ma'am.

Francesca DeMartino

Good morning and welcome to Pfizer's earnings call. I'm Francesca DeMartino, Chief Investor Relations Officer. On behalf of the Pfizer team, thank you for joining us. This call is being made available via audio webcast at pfizer.com. Earlier this morning, we released our results for the second quarter of 2024 via a press release that is available on our website at pfizer.com. I'm joined today by Dr. Albert Bourla, our Chairman and CEO; and Dave Denton, our CFO. Albert and Dave have some prepared remarks and we will then open the call for questions. Joining for the Q&A session, we also have Dr. Chris Boshoff, EVP and Chief Oncology

Recommended For You

About PFE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on PFE